Predicted Trait | |
Reported Trait | Malignant neoplasm of ovary |
Mapped Trait(s) | ovarian neoplasm (EFO_0003893) |
Additional Trait Information | PheCode 184.11 |
Score Construction | |
PGS Name | PRSWEB_PHECODE184.11_GWAS-Catalog-r2019-05-03-X184.11_P_5e-08_UKB_20200608 |
Development Method | |
Name | GWAS Hits |
Parameters | LD Clumping (MAF >= 1%, r^2 <= 0.1) & P<=5e-08 |
Variants | |
Original Genome Build | GRCh37 |
Number of Variants | 21 |
Effect Weight Type | NR |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000118 |
Citation (link to publication) | Fritsche LG et al. Am J Hum Genet (2020) |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST004462 Europe PMC: 28346442 |
85,426 individuals | European | NR |
GWAS Catalog: GCST004480 Europe PMC: 28346442 |
53,978 individuals | European | NR |
GWAS Catalog: GCST004478 Europe PMC: 28346442 |
54,990 individuals | European | NR |
GWAS Catalog: GCST004415 Europe PMC: 28346442 |
63,347 individuals | European | NR |
GWAS Catalog: GCST004419 Europe PMC: 28346442 |
43,507 individuals | European | NR |
GWAS Catalog: GCST004481 Europe PMC: 28346442 |
43,907 individuals | European | NR |
GWAS Catalog: GCST004479 Europe PMC: 28346442 |
42,895 individuals | European | NR |
GWAS Catalog: GCST001917 Europe PMC: 23544013 |
2,727 individuals | European | NR |
GWAS Catalog: GCST002748 Europe PMC: 25581431 |
13,491 individuals | European | NR |
GWAS Catalog: GCST004414 Europe PMC: 28346442 |
19,036 individuals | European | NR |
GWAS Catalog: GCST000455 Europe PMC: 19648919 |
4,170 individuals | European | NR |
GWAS Catalog: GCST004417 Europe PMC: 28346442 |
42,307 individuals | European | NR |
GWAS Catalog: GCST001258 Europe PMC: 21964575 |
42,247 individuals | European | NR |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | Phenotype Definitions & Methods | Age of Study Participants | Participant Follow-up Time | Additional Ancestry Description | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
Europe PMC: 32991828 |
[
|
European | UKB | PheCode:184.11; ICD9:183.0; ICD10:C56 | — | — | — | — |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM001229 | PSS000572| European Ancestry| 5,196 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Malignant neoplasm of ovary | OR: 1.12 [1.021, 1.23] β: 0.114 (0.0475) |
AUROC: 0.532 [0.506, 0.559] | Nagelkerke's Pseudo-R²: 0.00239 Brier score: 0.0827 Odds Ratio (OR, top 1% vs. Rest): 0.923 [0.347, 2.45] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE184.11_GWAS-Catalog-r2019-05-03-X184.11_P_5e-08_UKB_20200608 |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS000572 | PheCode:184.11; ICD9:183.0; ICD10:C56 | — | [
|
— | European | — | UKB | — |